These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 473052)

  • 21. [Effect of serum proteins on erythrocyte and thrombocyte aggregation].
    Mikheian EE; Akopov SE; Tunian IuS
    Patol Fiziol Eksp Ter; 1982; (1):23-5. PubMed ID: 7070851
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardioactive glycosides, hematic serotonin and platelet aggregation].
    Corradi L; Venco A; Malamani V
    Boll Soc Ital Cardiol; 1978; 23(3):499-504. PubMed ID: 753357
    [No Abstract]   [Full Text] [Related]  

  • 23. Gastrointestinal blood loss in patients undergoing maintenance dialysis.
    Wizemann V; Buddensiek P; de Boor J; Grebe S; Schütterle G
    Kidney Int Suppl; 1983 Dec; 16():S218-20. PubMed ID: 6588252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of ciprofloxacin on epinephrine and collagen induced thrombocyte aggregation in vitro on dialysis patients].
    Reuter HD; Thiele S; Hönig R
    Arzneimittelforschung; 1988 May; 38(5):727-9. PubMed ID: 3415718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet function in patients on long term peritoneal dialysis.
    Lindsay RM; Friesen M; Koens F; Linton AL; Oreopoulos D; de Veber G
    Clin Nephrol; 1976 Aug; 6(2):335-9. PubMed ID: 954241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on platelet aggregation and 14C-serotonin release in patients with uremia].
    Kang ZQ; Wang Z; Cui W; Li W
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Dec; 7(6):429-33. PubMed ID: 3011296
    [No Abstract]   [Full Text] [Related]  

  • 27. Propyl gallate-induced platelet aggregation in patients with end-stage renal disease: the influence of the haemodialysis procedure.
    Eleftheriadis T; Antoniadi G; Liakopoulos V; Tsiandoulas A; Barboutis K; Stefanidis I
    Nephrology (Carlton); 2006 Feb; 11(1):3-8. PubMed ID: 16509924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thrombocyte count and functions in patients with chronic renal insufficiency of different etiology].
    Belitskaia GA
    Vrach Delo; 1974 Mar; (3):67-70. PubMed ID: 4468671
    [No Abstract]   [Full Text] [Related]  

  • 29. [The microvascular bed of the nail matrix in patients with chronic uremia].
    Agaev MM; Gamidov IM
    Ter Arkh; 1989; 61(12):86-9. PubMed ID: 2629154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Microcirculatory disorders in the genesis of sclerodermic nephropathy].
    Anikina NV; Guseva NG; Mach ES
    Ter Arkh; 1986; 58(8):62-5. PubMed ID: 3532413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased release of prostacyclin-like activity from rat aorta by plasma from patients with hepatic or renal failure.
    Chamone DA; Van Hoof A; Vermylen J
    Arq Gastroenterol; 1987; 24(1):16-9. PubMed ID: 3329903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Method of determination of thrombocyte and erythrocyte aggregation].
    Liusov VA; Belousov IuB; Savenkov MP
    Lab Delo; 1976; (8):463-8. PubMed ID: 66396
    [No Abstract]   [Full Text] [Related]  

  • 33. Serotonin and platelet activation during treatment with isradipine.
    Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Free cytoplasmic calcium and thrombocyte aggregation in patients with ischemic heart disease. The effect of ADP, thrombocyte activation factor and serotonin].
    Panchenko EP; Shalaev SV; Men'shikov MIu; Tkachuk VA; Gratsianskiĭ NA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):90-6. PubMed ID: 3801147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis.
    Sirolli V; Strizzi L; Di Stante S; Robuffo I; Procopio A; Bonomini M
    Thromb Haemost; 2001 Sep; 86(3):834-9. PubMed ID: 11583316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biological dyschronism and circadian organization of serotonin, noradrenaline and platelet aggregation].
    Marconi G
    Minerva Med; 1992 Mar; 83(3):149-53. PubMed ID: 1553064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Erythrocyte deformability in acute and chronic kidney failure patients].
    Grinshteĭn IuI; Kalinina IA; Vitman TV
    Ter Arkh; 1986; 58(12):91-3. PubMed ID: 3824225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hemorheologic findings in patients with ischemic heart disease].
    Kunsch R; Bull K; Moufti M; Richter T; Schäbitz J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(5):803-5. PubMed ID: 2481631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "In vitro" inhibition of platelet aggregation by uremic middle molecules.
    Gallice P; Fournier N; Crevat A; Saingra S; Frayssinet R; Murisasco A; Sicardi F
    Biomedicine; 1980; 33(6):185-8. PubMed ID: 7213919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.